Compugen Ltd.
CGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $27,864 | $33,459 | $7,500 | $6,000 |
| % Growth | -16.7% | 346.1% | 25% | – |
| Cost of Goods Sold | $7,930 | $2,004 | $975 | $680 |
| Gross Profit | $19,934 | $31,455 | $6,525 | $5,320 |
| % Margin | 71.5% | 94% | 87% | 88.7% |
| R&D Expenses | $24,810 | $34,472 | $30,648 | $28,694 |
| G&A Expenses | $9,439 | $9,731 | $10,319 | $10,858 |
| SG&A Expenses | $10,015 | $9,975 | $11,251 | $11,700 |
| Sales & Mktg Exp. | $576 | $244 | $932 | $842 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $34,825 | $44,447 | $41,899 | $40,394 |
| Operating Income | -$14,891 | -$12,992 | -$35,374 | -$35,074 |
| % Margin | -53.4% | -38.8% | -471.7% | -584.6% |
| Other Income/Exp. Net | $5,182 | $3,208 | $1,738 | $871 |
| Pre-Tax Income | -$9,709 | -$9,784 | -$33,636 | -$34,203 |
| Tax Expense | $4,522 | $8,970 | $58 | $0 |
| Net Income | -$14,231 | -$18,754 | -$33,694 | -$34,203 |
| % Margin | -51.1% | -56.1% | -449.3% | -570.1% |
| EPS | -0.16 | -0.21 | -0.39 | -0.41 |
| % Growth | 23.8% | 46.2% | 4.9% | – |
| EPS Diluted | -0.16 | -0.21 | -0.39 | -0.41 |
| Weighted Avg Shares Out | 89,528 | 87,633 | 86,556 | 84,204 |
| Weighted Avg Shares Out Dil | 89,528 | 87,633 | 86,556 | 84,204 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,236 | $3,241 | $1,437 | $894 |
| Interest Expense | $34 | $31 | $27 | $25 |
| Depreciation & Amortization | $486 | $476 | $482 | $461 |
| EBITDA | -$14,405 | -$12,516 | -$33,127 | -$34,613 |
| % Margin | -51.7% | -37.4% | -441.7% | -576.9% |